Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Direct Meds vs Ro

Ro costs $100 less a month.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Direct Meds logo

Direct Meds

6.4
★★★☆☆3.2/5

Best for: compounded semaglutide at $249/month

Visit Direct Meds →
VS
Ro logo

Ro

6.7
★★★☆☆3.4/5

Best for: knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC

Visit Ro →

If you are choosing between Direct Meds and Ro, the first difference is cost: Ro is $100 a month cheaper at the entry price. Ro leads our six-part score, 6.7 to 6.4. One of the two has an FDA warning letter on record, covered below.

Direct Meds vs Ro price

Ro is the cheaper way in: $149 a month against $249 a month at Direct Meds. That is $100 less each month (40% lower), or about $1,200 over a year of treatment.

Medications and formats

Direct Meds and Ro do not overlap on medication; only Direct Meds lists semaglutide and tirzepatide; only Ro lists orforglipron.

On format, Direct Meds prices compounded injections, while Ro prices brand-name pens.

If you want the FDA-approved brand rather than a compounded version, Ro is the only one of the two with a brand-name price.

Where each one treats patients

Neither Direct Meds nor Ro publishes the states it serves, so enter your state at the very start of each sign-up.

Pricing

Direct Meds

SublingualCompounded
$249/mo
semaglutide

'As low as $249' per month, on a 90-day supply billed monthly; some doses run as low as $237/mo.

InjectionCompounded
$297/mo
semaglutide

'As low as $297' per month ($9.58 a day), an 84-day three-pack billed monthly.

SublingualCompounded
$299/mo
tirzepatide

'As low as $299' per month ($9.65 a day) on a 90-day supply billed monthly. Down from $399 earlier.

InjectionCompounded
$399/mo
tirzepatide

'As low as $399' per month ($12.87 a day).

Ro

Foundayo (lowest dose, cash pay)Brand-name
$149/mo
orforglipron

Additional membership fees apply

What each price covers

Both prices cover the clinician visit.

Direct Meds' price also covers the medication itself and shipping, which Ro does not claim.

Ro's price also covers lab work and coaching, which Direct Meds does not claim.

Direct Meds is silent on lab work and coaching.

Ro is silent on shipping.

That matters most for the drug: unless Ro confirms otherwise, budget for medication on top of its listed price.

Direct Meds

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Ro

Covered by the monthly price

Medication

Charged on top

Clinician visits

In the price

Shipping

Not stated

Lab work

In the price

Coaching

In the price

Where each one scores higher

Overall, Ro scores 6.7 and Direct Meds 6.4 out of 10.

Direct Meds is stronger on effectiveness (10.0 vs 8.0) and support (7.0 vs 5.5).

Ro is stronger on value (5.0 vs 3.7) and trust & safety (8.0 vs 3.5).

User experience and accessibility are within half a point.

How we score

Direct Meds

6.4/10

Overall

Ro

6.7/10

Value25%

3.7A
vs
B
5.0

Effectiveness25%

10.0A
vs
B
8.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

3.5A
vs
B
8.0

Accessibility10%

5.0A
vs
B
5.0

Support10%

7.0A
vs
B
5.5

FDA warning letters

The FDA sent Direct Meds a warning letter dated September 9, 2025 (letter 716822), and it is still open.

Ro has no FDA warning letter on record with us.

Features & Coverage

FeatureDirect MedsRo
Starting Price$249/mo✓$149/mo
Features5 features✓7 features
States AvailableNot disclosedNot disclosed
Compounded✓ Yes—
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About Direct Meds

The FDA sent Direct Meds a warning letter in September 2025 over misleading marketing, and customers have reported a documented pattern of unexpected 3-month commitment charges. We list the company with both disclosed in full; read the warnings and the cons first. Its products are compounded semaglutide and tirzepatide, sold from Utah in injection and sublingual form.

Read our full Direct Meds review →

About Ro

Foundayo (orforglipron), the new oral GLP-1 from Eli Lilly, joined Ro on April 9 2026 at $149/month for the lowest dose, membership on top. Beside it sit compounded semaglutide and the brand-name pair, Zepbound and Wegovy. No obesity care formulary in the category is more comprehensive. In the US, only a handful of direct-to-patient telehealth companies are larger.

Read our full Ro review →

Pros & Cons

Direct Meds

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping

Watch-outs

  • Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $299 a month, 20% above the $250 median for compounded tirzepatide across the sellers we compare
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued Direct Meds a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Ro

What we like

  • Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes clinician visits, lab work and coaching
  • Names Roman Health Pharmacy LLC as the pharmacy that fills its prescriptions, which most sellers do not
  • We found no FDA warning letters issued to Ro

Watch-outs

  • Not included in the monthly price: medication
  • Confirm it serves your state before you start the intake

Our Verdict

Winner: Direct Meds

Direct Meds is where we would start, above all for compounded semaglutide at $249/month. Ro undercuts it by $100 a month, so if the monthly bill is what decides it, Ro is the pick. Ro fits better if knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC is your priority.

Choose Direct Meds if…

You want compounded semaglutide at $249/month and an opening price near $249 a month.

Choose Ro if…

You want knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC and an opening price near $149 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

5.9

Wellorithm

Compounded semaglutide at $247/month

6.6

Willow

Seeing what it charges before you answer any medical questions

6.5

Sesame Care

Oral orforglipron alongside the injectables

Direct Meds vs Ro: FAQ

Ro. It starts at $149 a month; Direct Meds starts at $249 a month, $100 more per month.
No. Direct Meds lists semaglutide and tirzepatide; Ro lists orforglipron.
Direct Meds does not publish where it ships; Ro does not publish where it ships. Confirm your state before paying.
Both include the clinician visit. Only Direct Meds includes the medication itself and shipping. Only Ro includes lab work and coaching.
Direct Meds has an open FDA warning letter from September 9, 2025. Ro has none.
Direct Meds pays us a commission on sign-ups through our links; Ro does not. Scores are computed the same way for both.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.